Denka Company Limited

Tokyo Stock Exchange 4061.T

Denka Company Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 4.70 M

Denka Company Limited Net Cash Used Provided By Financing Activities is USD 4.70 M for the year ending March 31, 2024, a -96.60% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Denka Company Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 138.20 M, a 236.32% change year over year.
Denka Company Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD -101.38 M, a -67.42% change year over year.
Denka Company Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -60.56 M, a -168.23% change year over year.
Denka Company Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 88.75 M, a 217.03% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 4061.T

Denka Company Limited

CEO	Mr. Toshio Imai
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	Nihonbashi Mitsui Tower
Employees	6,514
Sector	Materials
Industries Plastics 3D Printing Ceramics Chemicals & Advanced Materials Composite Materials Containers & Packaging Glass Petrochemicals

Description

Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years